APA (7th ed.) Citation

Mayer, E. L., Dallabrida, S. M., Rupnick, M. A., Redline, W. M., Hannagan, K., Ismail, N. S., . . . Beckman, J. A. (2011). Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans. Hypertension (0194911X), 58(1), 85. https://doi.org/10.1161/HYPERTENSIONAHA.110.168120

Chicago Style (17th ed.) Citation

Mayer, Erica L., Susan M. Dallabrida, Maria A. Rupnick, Whitney M. Redline, Keri Hannagan, Nesreen S. Ismail, Harold J. Burstein, and Joshua A. Beckman. "Contrary Effects of the Receptor Tyrosine Kinase Inhibitor Vandetanib on Constitutive and Flow-stimulated Nitric Oxide Elaboration in Humans." Hypertension (0194911X) 58, no. 1 (2011): 85. https://doi.org/10.1161/HYPERTENSIONAHA.110.168120.

MLA (9th ed.) Citation

Mayer, Erica L., et al. "Contrary Effects of the Receptor Tyrosine Kinase Inhibitor Vandetanib on Constitutive and Flow-stimulated Nitric Oxide Elaboration in Humans." Hypertension (0194911X), vol. 58, no. 1, 2011, p. 85, https://doi.org/10.1161/HYPERTENSIONAHA.110.168120.